Connect with us
Lakeway, NY — (US MARKET BUZZ) — 12/17/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock...
Celgene Corporation (NASDAQ:CELG)’s shares declined 0.84% to $86.05. The company on July 9 announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral,...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s shares gained 1.42% to $4.99. The company on July 15 announced that it was granted U.S. Patent No. 8,778,950, entitled “Cannabinoid Receptor...
Geron Corporation (NASDAQ:GERN)’s shares fell 4.95% to $2.88. The company on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s shares declined 0.93% to $5.32. The company on July 10 reported that Eisai Inc. has completed its planned increase of more than...
Celgene Corporation (NASDAQ:CELG)’s shares gained 0.35% to $87.83. The company on July 9 announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral,...
Celgene Corporation (NASDAQ:CELG)’s shares gained 2.10% to $87.52. The company on July 9 announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral,...
Amgen, Inc.(NASDAQ:AMGN)’s shares gained 2.65% to $120.97. The company on June 16 announced that it will collaborate with the National Cancer Institute (NCI), part of the...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s shares gained 5.95% to $13.71. The company on June 3 announced that its Marketing Authorization Application (MAA) for oral HETLIOZ™ (tasimelteon) capsules...